Global Intravenous Ibuprofen Market was worth USD 5.72 billion in 2017 and estimated to be growing at a CAGR of 20.0%, to reach USD 14.23 billion by 2022. Ibuprofen is a Non steroidal anti-Inflammatory drug used to treat pain and fever which can be causative of a disease, trauma or any major operation. In an intravenous form, the drug has a faster onset of action as compared to other forms. IV Ibuprofen is used to manage acute and post-operative pain.
Browse market data tables and in-depth TOC of the Intravenous Ibuprofen Market to 2022 @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/
Due to its faster onset of action and fast results, the market is expected to grow at a rapid rate during the forecast period. As it has been approved for paediatric use, the market is further expected to propel. Due to increased incidence of cardiovascular diseases, cancer and fever coupled with shifting trend to non-opoid drugs is further driving the market growth. However, the side effects associated with the use of ibuprofen and the lengthy approval processes are hampering the market growth.
Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/request-sample
The market for Intravenous Ibuprofen is broadly categorized into age group and indication. By age group the market is divided into adults and paediatrics. Adults are the major consumer base for intravenous ibuprofen. The paediatric segment is expected to grow at a substantial rate. By indication the market is further classified into fever and pain/inflammatory. Fever is projected to be the fastest growing segment. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Intravenous Ibuprofen market was dominated by North America. Asia Pacific is expected to grow at a high CAGR.
Some of the major companies dominating the market, by their products and services include Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi, and Laboratorios Valmorca, C.A.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/inquire
The scope of the report provides:
· The evaluation of the current market for your product or services and the future implications of the market
· Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
· Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
· Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
· The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
· The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
· Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
· Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
· Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
Order your copy of the report: https://www.marketdataforecast.com/cart/buy-now/intravenous-ibuprofen-market-6729/
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Follow us @ https://in.linkedin.com/company/market-data-forecast